70 related articles for article (PubMed ID: 19212346)
1. Melanoma inhibitor of apoptosis protein (ML-IAP) specific cytotoxic T lymphocytes cross-react with an epitope from the auto-antigen SS56.
Baek Sørensen R; Faurschou M; Troelsen L; Schrama D; Jacobsen S; Becker JC; Thor Straten P; Andersen MH
J Invest Dermatol; 2009 Aug; 129(8):1992-9. PubMed ID: 19212346
[TBL] [Abstract][Full Text] [Related]
2. The melanoma inhibitor of apoptosis protein: a target for spontaneous cytotoxic T cell responses.
Andersen MH; Reker S; Becker JC; thor Straten P
J Invest Dermatol; 2004 Feb; 122(2):392-9. PubMed ID: 15009721
[TBL] [Abstract][Full Text] [Related]
3. Immunity to the melanoma inhibitor of apoptosis protein (ML-IAP; livin) in patients with malignant melanoma.
Zhou J; Yuen NK; Zhan Q; Velazquez EF; Murphy GF; Giobbie-Hurder A; Hodi FS
Cancer Immunol Immunother; 2012 May; 61(5):655-65. PubMed ID: 22033581
[TBL] [Abstract][Full Text] [Related]
4. Anti-52 kDa Ro(SSA) autoantibodies in different autoimmune diseases preferentially recognize epitopes on the central region of the antigen.
Dorner T; Feist E; Wagenmann A; Kato T; Yamamoto K; Nishioka K; Burmester GR; Hiepe F
J Rheumatol; 1996 Mar; 23(3):462-8. PubMed ID: 8832984
[TBL] [Abstract][Full Text] [Related]
5. Identification of a SmD3 epitope with a single symmetrical dimethylation of an arginine residue as a specific target of a subpopulation of anti-Sm antibodies.
Mahler M; Fritzler MJ; Blüthner M
Arthritis Res Ther; 2005; 7(1):R19-29. PubMed ID: 15642139
[TBL] [Abstract][Full Text] [Related]
6. Cross-recognition between histones and La/SSB may account for anti-DNA reactivity in SLE patients.
Touloupi E; Routsias JG; Tzioufas AG
Clin Exp Immunol; 2005 Oct; 142(1):172-9. PubMed ID: 16178873
[TBL] [Abstract][Full Text] [Related]
7. Aberrant expression and potency as a cancer immunotherapy target of inhibitor of apoptosis protein family, Livin/ML-IAP in lung cancer.
Hariu H; Hirohashi Y; Torigoe T; Asanuma H; Hariu M; Tamura Y; Aketa K; Nabeta C; Nakanishi K; Kamiguchi K; Mano Y; Kitamura H; Kobayashi J; Tsukahara T; Shijubo N; Sato N
Clin Cancer Res; 2005 Feb; 11(3):1000-9. PubMed ID: 15709165
[TBL] [Abstract][Full Text] [Related]
8. The epitope study of alpha-fodrin autoantibody in primary Sjögren's syndrome.
Chen Q; Li X; He W; Zhang H; Gao A; Cheng Y; Lei J; Li S; Zeng L
Clin Exp Immunol; 2007 Sep; 149(3):497-503. PubMed ID: 17614976
[TBL] [Abstract][Full Text] [Related]
9. T cell reactivity to Sjögren's syndrome related antigen La(SSB).
Helsloot J; Sturgess A
J Rheumatol; 1997 Dec; 24(12):2340-7. PubMed ID: 9415639
[TBL] [Abstract][Full Text] [Related]
10. Peptides derived from self-proteins as partial agonists and antagonists of human CD8+ T-cell clones reactive to melanoma/melanocyte epitope MART1(27-35).
Loftus DJ; Squarcina P; Nielsen MB; Geisler C; Castelli C; Odum N; Appella E; Parmiani G; Rivoltini L
Cancer Res; 1998 Jun; 58(11):2433-9. PubMed ID: 9622085
[TBL] [Abstract][Full Text] [Related]
11. Mapping of epitopes on the La(SS-B) autoantigen of primary Sjögren's syndrome: identification of a cross-reactive epitope.
McNeilage LJ; Macmillan EM; Whittingham SF
J Immunol; 1990 Dec; 145(11):3829-35. PubMed ID: 1700996
[TBL] [Abstract][Full Text] [Related]
12. Reactivity of sera from systemic lupus erythematosus and Sjögren's syndrome patients with peptides derived from human immunodeficiency virus p24 capsid antigen.
Deas JE; Liu LG; Thompson JJ; Sander DM; Soble SS; Garry RF; Gallaher WR
Clin Diagn Lab Immunol; 1998 Mar; 5(2):181-5. PubMed ID: 9521140
[TBL] [Abstract][Full Text] [Related]
13. Analysis of autoantibodies to recombinant La (SS-B) peptides in systemic lupus erythematosus and primary Sjogren's syndrome.
Bini P; Chu JL; Okolo C; Elkon K
J Clin Invest; 1990 Feb; 85(2):325-33. PubMed ID: 1688881
[TBL] [Abstract][Full Text] [Related]
14. An antigen-targeted approach to adoptive transfer therapy of cancer.
Valmori D; Pittet MJ; Rimoldi D; Liénard D; Dunbar R; Cerundolo V; Lejeune F; Cerottini JC; Romero P
Cancer Res; 1999 May; 59(9):2167-73. PubMed ID: 10232604
[TBL] [Abstract][Full Text] [Related]
15. The antitumor effect of human cord blood-derived dendritic cells modified by the livin α gene in lung cancer cell lines.
Chen H; Jin Y; Chen T; Zhang M; Ma W; Xiong X; Tao X
Oncol Rep; 2013 Feb; 29(2):619-27. PubMed ID: 23152000
[TBL] [Abstract][Full Text] [Related]
16. Defective selection of thymic regulatory T cells accompanies autoimmunity and pulmonary infiltrates in Tcra-deficient mice double transgenic for human La/Sjögren's syndrome-B and human La-specific TCR.
Yaciuk JC; Pan Y; Schwarz K; Pan ZJ; Maier-Moore JS; Kosanke SD; Lawrence C; Farris AD
J Immunol; 2015 Feb; 194(4):1514-22. PubMed ID: 25582858
[TBL] [Abstract][Full Text] [Related]
17. Tumor-reactive, SSX-2-specific CD8+ T cells are selectively expanded during immune responses to antigen-expressing tumors in melanoma patients.
Ayyoub M; Rimoldi D; Guillaume P; Romero P; Cerottini JC; Valmori D; Speiser D
Cancer Res; 2003 Sep; 63(17):5601-6. PubMed ID: 14500401
[TBL] [Abstract][Full Text] [Related]
18. Preferential recognition of the phosphorylated major linear B-cell epitope of La/SSB 349-368 aa by anti-La/SSB autoantibodies from patients with systemic autoimmune diseases.
Terzoglou AG; Routsias JG; Avrameas S; Moutsopoulos HM; Tzioufas AG
Clin Exp Immunol; 2006 Jun; 144(3):432-9. PubMed ID: 16734612
[TBL] [Abstract][Full Text] [Related]
19. Induction of interferon-alpha by immune complexes or liposomes containing systemic lupus erythematosus autoantigen- and Sjögren's syndrome autoantigen-associated RNA.
Lövgren T; Eloranta ML; Kastner B; Wahren-Herlenius M; Alm GV; Rönnblom L
Arthritis Rheum; 2006 Jun; 54(6):1917-27. PubMed ID: 16729300
[TBL] [Abstract][Full Text] [Related]
20. T cell epitope mimicry between Sjögren's syndrome Antigen A (SSA)/Ro60 and oral, gut, skin and vaginal bacteria.
Szymula A; Rosenthal J; Szczerba BM; Bagavant H; Fu SM; Deshmukh US
Clin Immunol; 2014; 152(1-2):1-9. PubMed ID: 24576620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
